ARCA biopharma, Inc.
NASDAQ:ABIO
28.8 (USD) • At close August 30, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15.251 | 46.861 | 3.888 | 0.545 | 0.195 | 2.29 | 26.433 | 24.59 | 15.604 | 6.4 | 9.6 | 6.2 | 0.4 |
| Cost of Revenue
| 0.111 | 0.114 | 0.091 | 0.093 | 0.089 | 0.022 | 0.027 | 0.024 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3.124 | -3 | -2 | -1.2 | -0.4 |
| Gross Profit
| -0.111 | -0.114 | -0.091 | -0.093 | -0.089 | -0.022 | -0.027 | -0.024 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15.251 | 46.861 | 3.888 | 0.545 | 0.195 | 2.29 | 26.433 | 24.59 | 18.728 | 9.4 | 11.6 | 7.4 | 0.8 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1.2 | 1.469 | 1.208 | 1.194 | 2 |
| Reseach & Development Expenses
| 1.013 | 4.749 | 13.832 | 4.992 | 1.833 | 4.239 | 14.076 | 12.348 | 7.063 | 5.625 | 2.928 | 1.092 | 2.315 | 3.106 | 10.01 | 27.764 | 42.654 | 89.37 | 57.778 | 39.97 | 33.084 | 50.157 | 46.506 | 29.018 | 18.2 | 19.2 | 9.4 | 3.7 |
| General & Administrative Expenses
| 6.283 | 5.847 | 5.503 | 4.774 | 3.981 | 3.879 | 4.636 | 4.265 | 4.392 | 4.068 | 4.012 | 3.227 | 5.046 | 6.069 | 12.84 | 14.939 | 20.762 | 30.632 | 15.801 | 8.702 | 17.223 | 18.144 | 13.452 | 9.315 | 8.1 | 9.5 | 4.9 | 1.7 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 6.283 | 5.847 | 5.503 | 4.774 | 3.981 | 3.879 | 4.636 | 4.265 | 4.392 | 4.068 | 4.012 | 3.227 | 5.046 | 6.069 | 12.84 | 14.939 | 20.762 | 30.632 | 15.801 | 8.702 | 17.223 | 18.144 | 13.452 | 9.315 | 8.1 | 9.5 | 4.9 | 1.7 |
| Other Expenses
| 0 | -0.005 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.342 | 2.336 | 24.46 | 0.004 | 0.167 | 1.225 | 0 | 0 | 3.124 | 3 | 2 | 1.2 | 0.4 |
| Operating Expenses
| 7.296 | 10.596 | 19.335 | 9.766 | 5.814 | 8.118 | 18.712 | 16.613 | 11.455 | 9.693 | 6.94 | 4.319 | 7.361 | 9.175 | 22.85 | 41.361 | 63.416 | 144.462 | 73.583 | 48.839 | 51.532 | 68.301 | 59.958 | 41.457 | 29.3 | 30.7 | 15.5 | 5.8 |
| Operating Income
| -7.296 | -10.596 | -19.335 | -9.766 | -5.814 | -8.118 | -18.712 | -16.613 | -11.455 | -9.693 | -6.94 | -4.319 | -7.361 | -9.175 | -36.733 | -33.251 | -18.891 | -140.574 | -73.038 | -48.644 | -49.242 | -43.935 | -36.193 | -22.729 | -19.9 | -19.1 | -8.1 | -5 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.18 | -0.403 | -36.156 | -134.015 | -249.456 | -21.503 | -1.662 | -1.472 | -1.457 | -3.109 | -1.99 | -1.306 | -12.5 |
| Total Other Income Expenses Net
| 1.957 | 0.67 | 0.013 | 0.019 | 0.165 | 0.154 | 0.161 | 0.169 | 0.01 | 0.004 | 0.001 | -0.001 | 1.997 | 0.755 | 11.431 | -10.43 | 6.59 | 7.797 | 1.427 | -0.298 | -0.945 | -6.621 | -0.572 | 0 | 0 | 2.7 | 1.7 | 0.3 |
| Income Before Tax
| -5.339 | -9.926 | -19.322 | -9.747 | -5.649 | -7.964 | -18.551 | -16.444 | -11.445 | -9.689 | -6.939 | -4.32 | -5.364 | -8.42 | -11.419 | -29.923 | -12.301 | -130.553 | -71.611 | -52.489 | -50.187 | -76.791 | -36.765 | 0 | 0 | -16.4 | -6.4 | -4.7 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.962 | -0.262 | -33.578 | -131.396 | -269.174 | -21.916 | -2.905 | -1.495 | 0 | 0 | -1.708 | -1.032 | -11.75 |
| Income Tax Expense
| -0.111 | -0.67 | -0.091 | -0.009 | -0.167 | -0.031 | -0.061 | 0.188 | 0.014 | 0.007 | 0.005 | 0.002 | 0.005 | 0.763 | -2.281 | 3.813 | -4.254 | -10.021 | -1.427 | 3.845 | 0.945 | 3.11 | -0.293 | -0.476 | -1.4 | -2.7 | -1.6 | -0.2 |
| Net Income
| -5.339 | -9.256 | -19.231 | -9.738 | -5.482 | -7.931 | -18.49 | -16.463 | -11.445 | -9.689 | -6.939 | -4.32 | -5.364 | -8.42 | -9.138 | -29.923 | -12.301 | -130.553 | -71.611 | -52.489 | -50.187 | -44.978 | -36.472 | -22.253 | -18.5 | -16.4 | -6.5 | -4.8 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.962 | -0.262 | -33.578 | -131.396 | -269.174 | -21.916 | -1.702 | -1.483 | -1.426 | -2.891 | -1.708 | -1.048 | -12 |
| EPS
| -0.37 | -0.64 | -1.38 | -2.07 | -4.15 | -10.31 | -31.91 | -32.68 | -32.76 | -59.55 | -101.32 | -244.8 | -403.98 | -748.38 | -974.1 | -29,863.27 | -3,487.67 | -38,375.37 | -26,231.14 | -25,717.3 | -36,053.88 | -88,365.42 | -85,816.47 | -73,685.43 | -64,236.11 | -57,543.86 | -23,214.29 | -17,142.86 |
| EPS Diluted
| -0.37 | -0.64 | -1.38 | -2.07 | -4.15 | -10.31 | -31.91 | -32.68 | -32.76 | -59.55 | -101.32 | -244.8 | -403.98 | -748.38 | -974.1 | -29,863.27 | -3,487.67 | -38,375.37 | -26,231.14 | -25,717.3 | -36,053.88 | -88,365.42 | -85,816.47 | -73,685.43 | -64,236.11 | -57,543.86 | -23,214.29 | -17,142.86 |
| EBITDA
| -7.296 | -10.596 | -19.322 | -9.738 | -5.553 | -7.934 | -18.545 | -16.124 | -11.422 | -9.674 | -6.909 | -4.274 | -6.757 | -8.074 | -22.176 | -17.584 | -14.212 | -137.392 | -70.37 | -44.36 | -42.488 | -33.539 | -30.298 | -19.605 | -16.9 | -17.1 | -6.9 | -4.6 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.153 | -0.253 | -29.046 | -129.613 | -227.487 | -18.554 | -1.269 | -1.197 | -1.256 | -2.641 | -2.063 | -1.387 | -12.25 |